The Washington Post Cites Public Citizen’s Report On Remdesivir’s Publicly Funded Development

By Christopher Rowland

“Two other nonprofit watchdog groups, Knowledge Ecology International and Public Citizen, also have documented the large taxpayer-funded contributions toward the drug. Public Citizen estimates public investment at a minimum of $70 million.”

“‘Gilead did not make this drug alone. The public helped make it, and the public has a stake,’ said Peter Maybarduk, director of the access to medicines program at Public Citizen.”

 

Read the full story here.